Lung cancer is the leading cancer killer in the world, and only about 15 percent of cases are diagnosed at an early stage, when it’s most treatable. But two preliminary studies that are scheduled to be presented at a medical meeting this week suggest that scientists are moving closer to developing new screening tests that could potentially detect lung cancer in its earliest stages.
